Flow mediated dilatation in systemic sclerosis: Effects of iloprost treatment

被引：0
|
作者：
Giannattasio, C
Gentile, G
Failla, M
Pozzi, M
Gardinali, M
Meles, E
Zazzeron, C
Fantini, E
Maestroni, S
Mancia, G
机构：
[1] Clin Med Bicocca Univ, S Gerardo H, Monza, Italy
[2] S Gerardo H, Div Med 2, Monza, Italy
[3] Ist Interuniv Fisiol Clin Ipertens, Milan, Italy
来源：
JOURNAL OF HYPERTENSION | 2003年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S160 / S160
页数：1
相关论文
共 50 条
  • [41] Iloprost infusion does not reduce oxidative stress in systemic sclerosis
    Volpe, Alessandro
    Biasi, Domenico
    Caramaschi, Paola
    Bambara, Lisa Maria
    Carletto, Antonio
    Degan, Maurizio
    Minuz, Pietro
    RHEUMATOLOGY INTERNATIONAL, 2008, 28 (04) : 335 - 337
  • [42] Assessment of microcirculatory changes in response to IV iloprost in systemic sclerosis
    Shah, P.
    Moore, T. L.
    Herrick, A.
    RHEUMATOLOGY, 2007, 46 : I77 - I77
  • [43] Exhaled nitric oxide and pulmonary response to iloprost in systemic sclerosis
    Marczin, N
    Riedel, B
    Royston, D
    Yacoub, M
    LANCET, 1998, 352 (9125): : 405 - 406
  • [44] The safety of iloprost in systemic sclerosis in a real-life experience
    Bellando-Randone, S.
    Bruni, C.
    Lepri, G.
    Fiori, G.
    Bartoli, F.
    Conforti, M. L.
    Moggi-Pignone, A.
    Guiducci, S.
    Giuggioli, D.
    Colaci, M.
    Spinella, A.
    Ferri, C.
    Matucci-Cerinic, M.
    CLINICAL RHEUMATOLOGY, 2018, 37 (05) : 1249 - 1255
  • [45] The safety of iloprost in systemic sclerosis in a real-life experience
    S. Bellando-Randone
    C. Bruni
    G. Lepri
    G. Fiori
    F. Bartoli
    ML Conforti
    A. Moggi-Pignone
    S. Guiducci
    D. Giuggioli
    M. Colaci
    A. Spinella
    C. Ferri
    M. Matucci-Cerinic
    Clinical Rheumatology, 2018, 37 : 1249 - 1255
  • [46] Flow-mediated dilatation
    Raitakari, OT
    Celermajer, DS
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 50 (05) : 397 - 404
  • [47] Longterm Treatment with Endothelin Receptor Antagonist Bosentan and Iloprost Improves Fingertip Blood Perfusion in Systemic Sclerosis
    Cutolo, Maurizio
    Ruaro, Barbara
    Pizzorni, Carmen
    Ravera, Francesca
    Smith, Vanessa
    Zampogna, Giuseppe
    Paolino, Sabrina
    Seriolo, Bruno
    Cimmino, Marco
    Sulli, Alberto
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (05) : 881 - 886
  • [48] Radial artery flow-mediated dilatation in heart failure patients - Effects of pharmacological and nonpharmacological treatment
    Giannattasio, C
    Achilli, F
    Grappiolo, A
    Failla, M
    Meles, E
    Gentile, G
    Calchera, I
    Capra, A
    Baglivo, J
    Vincenzi, A
    Sala, L
    Mancia, G
    HYPERTENSION, 2001, 38 (06) : 1451 - 1455
  • [49] Effects of acute administration of iloprost on the cardiac autonomic nervous system and ventricular repolarisation in patients with systemic sclerosis
    Guideri, F.
    Acampa, M.
    Rechichi, S.
    Capecchi, P. L.
    Lazzerini, P. E.
    Galeazzi, M.
    Auteri, A.
    Laghi-Pasini, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (06) : 836 - U151
  • [50] Imaging the anti-inflammatory Effects of iloprost of Fluorescence of optical Imaging in Patients with a Progressive Systemic Sclerosis
    Drummer, K.
    Jung, C.
    Boettcher, J.
    Oelzner, P.
    Hansch, A.
    Wolf, G.
    Pfeil, A.
    INTERNIST, 2015, 56 : 51 - 51
12345